ESMO Preceptorship on Immuno-Oncology 2018: Lugano
![ESMO Preceptorship on Immuno-Oncology Lugano 2018](/var/esmo/storage/images/media/images/conferences/2018/preceptorships-2018/esmo-preceptorship-on-immuno-oncology-lugano-2018/2367228-1-eng-GB/ESMO-Preceptorship-on-Immuno-Oncology-Lugano-2018.jpg)
- Start date
- 04 May 2018
- End date
- 05 May 2018
- Location
- Lugano, Switzerland
Learning objectives
- To understand the basics of tumour immunology
- To learn about the essentials of immunotherapies and their applications in cancer medicine
- To learn about the status of development and clinical experience of immunotherapy in different tumour types
Accreditation
The programme of this event has been accredited with 11 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Co-Chairs
- Rolf A. Stahel, Switzerland
- John B.A.G. Haanen, Netherlands
- Solange Peters, Switzerland